CytoSorbents Announces the Launch and Immediate Availability of the PuriFi(TM) Blood Pump in the European Union

Stock Information for Citius Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Citius Pharmaceuticals Inc.

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
CytoSorbents to Present at the H.C. Wainwright 26?? Annual Global Investment Conference
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.